SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-015883
Filing Date
2022-06-24
Accepted
2022-06-24 16:03:03
Documents
13
Period of Report
2022-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20220624_8k.htm   iXBRL 8-K 56785
  Complete submission text file 0001437749-22-015883.txt   209891

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20220624.xsd EX-101.SCH 4037
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20220624_def.xml EX-101.DEF 13896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20220624_lab.xml EX-101.LAB 18218
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20220624_pre.xml EX-101.PRE 13918
7 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20220624_8k_htm.xml XML 4373
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 221040000
SIC: 2860 Industrial Organic Chemicals